CV Lattes
ResearcherID
Universidade de São Paulo (USP). Faculdade de Medicina (FM) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Medical Doctor, Infectious Diseases Specialist and Immunologist, is Associate Professor at the Division of Clinical Immunology and Allergy, School of Medicine, University of Sao Paulo. Research Leader at the LIM-60 laboratory, where conducts translational research in infectious diseases. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Instituto Butantan (IB), has always worked to answer public health challenges and has a long tradition in the development and manufacturing of vaccines and antibodies. This project addresses both areas, influenza vaccines and human monoclonal antibodies, focusing on critical targets that demand attention and require the use of strategies based on solid scientific, clinical, regulatory and…
The Instituto Butantan (IBu) is a research, innovation and production institute with national and world recognition, whose fundamental mission is to meet the demands of public health, contributing to the promotion of the population's well-being. It has an important collection of biological material, including primary and human cell lineages and cultures, human biological material obtained…
The Institute for Investigation in Immunology, iii, initially a Millenium Institute created in 2001, studies infectious diseases, HIV/AIDS, allergy, autoimmune diseases, transplantation and primary immunodeficiency. These diseases have strong immunological components, and are health problems that affect millions in our country and throughout the world. Besides the social and economic rele…
Yellow Fever is an infectious and non-contagious disease caused by the Yellow Fever Virus (YFV), an arbovirus belonging to the Flaviviridae family. It has a broad spectrum of symptoms, ranging from asymptomatic to severe and fatal cases. Recently, a study conducted by the Laboratory of Allergy and Clinical Immunopathology, showed that absolute neutrophil count in peripheral blood was inde…
Initial results of clinical trials of pre-exposure prophylaxis (PrEP), in the form of an oral pill daily indicate that this strategy can be extremely useful for the change of scenery needed in the fight against HIV infection. The World Health Organization (WHO) states that PrEP can be prioritized for high-risk populations including men who have sex with men (MSM), intravenous drug users a…
In this proposal, we request support for the visiting researcher Prof. Dr. Lucio Gama to the Division of Clinical Immunology and Allergy and the Graduation Program on Allergy and Immunopathology, both at the School of Medicine, University of Sao Paulo. Prof. Gama will develop his activities in teaching and research in our group, through three monthly visits during 2012, besides continuous…
(Only some records are available in English at this moment)
Yellow Fever is an infectious and non-contagious disease caused by the Yellow Fever Virus (YFV), an arbovirus belonging to the Flaviviridae family. It has a broad spectrum of symptoms, ranging from asymptomatic to severe and fatal cases. Recently, a study conducted by the Laboratory of Allergy and Clinical Immunopathology, showed that absolute neutrophil count in peripheral blood was inde…
Yellow fever (YF) is an arbovirus disease, caused by a virus and transmitted by an infected mosquito. The incubation period is from 3 to 6 days. The disease progresses with fever, malaise, chills, headache and low back pain, in addition to generalized myalgia, nausea and dizziness. YF does not have specific treatment, and its management is only carried out with clinical care. To date, the…
Yellow fever is still considered a public health problem in several regions of the world, including Brazil, where a major outbreak has recently occurred at southeastern region, with more than 290 confirmed cases and 97 deaths. The yellow fever vaccine, developed over eight decades ago, is highly effective at conferring protective immunity against yellow fever virus (YFV) for a period of 1…
(Only some records are available in English at this moment)
| 3 / 3 | Ongoing research grants |
| 9 / 5 | Completed research grants |
| 13 / 7 | Completed scholarships in Brazil |
| 25 / 15 | All research grants and scholarships |
| Associated processes | |